# FDA Inspection 1038967 - BrightGene Pharmaceutical Co., Ltd. - December 08, 2017

Source: https://www.keypedia.com/records/fda_inspections/brightgene-pharmaceutical-co-ltd/ee9f58ae-6c34-45c4-8be2-1150961abf5f
Source feed: FDA_Inspections

> FDA Inspection 1038967 for BrightGene Pharmaceutical Co., Ltd. on December 08, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1038967
- Company Name: BrightGene Pharmaceutical Co., Ltd.
- Inspection Date: 2017-12-08
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1240231 - 2024-04-26](https://www.keypedia.com/records/fda_inspections/brightgene-pharmaceutical-co-ltd/27b2de98-edfa-4d49-be29-fda25ed22ba2)
- [FDA Inspection 942083 - 2015-09-10](https://www.keypedia.com/records/fda_inspections/brightgene-pharmaceutical-co-ltd/75c108ef-6557-4b3c-828d-06d505e009b1)
- [FDA Inspection 831367 - 2013-03-14](https://www.keypedia.com/records/fda_inspections/brightgene-pharmaceutical-co-ltd/7e3eb562-8e2f-4393-906d-c80696b8aa1c)

Company: https://www.keypedia.com/companies/brightgene-pharmaceutical-co-ltd/532f1ca2-79a4-40bb-bf0e-3869fc8a2213

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c